Physician profile
Angela Cheng
NPI 1821222308
$3,080.30
in general payments reported to CMS, 2019-2025
18 companies · $36.91 in 2025
The $36.91 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $252 · 2021: $329 · 2022: $237 · 2023: $870 · 2024: $448 · 2025: $36.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $772.95 | 2023-2024 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Sientra, INC. | $535.05 | 2019-2021 | |
| Mentor Worldwide LLC | $383.54 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $254.73 | 2019-2022 | |
| Tela Bio, INC. | $191.28 | 2024 | Ovitex 2s |
| Bard Peripheral Vascular, INC. | $175.83 | 2021 | |
| Kerecis Limited | $161.87 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Axogen | $120.71 | 2020 | |
| Novartis Pharmaceuticals Corporation | $104.20 | 2023 | |
| Depuy Synthes Sales INC. | $80.06 | 2020-2022 | |
| Integra Lifesciences Corporation | $77.98 | 2019-2022 | |
| Tepha INC | $66.22 | 2019 | |
| Ethicon US, LLC | $62.38 | 2019-2020 | |
| Medical Device Business Services, INC. | $25.56 | 2019 | |
| Davol INC. | $23.24 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $16.29 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Tei Biosciences INC | $14.74 | 2019 | |
| Becton, Dickinson and Company | $13.67 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.